Literature DB >> 19059500

Mechanism of cell killing after ionizing radiation by a dominant negative DNA polymerase beta.

Sari Neijenhuis1, Manon Verwijs-Janssen, Ulla Kasten-Pisula, Gaby Rumping, Kerstin Borgmann, Ekkehard Dikomey, Adrian C Begg, Conchita Vens.   

Abstract

Several types of DNA lesion are induced after ionizing irradiation (IR) of which double strand breaks (DSBs) are expected to be the most lethal, although single strand breaks (SSBs) and DNA base damages are quantitatively in the majority. Proteins of the base excision repair (BER) pathway repair these numerous lesions. DNA polymerase beta has been identified as a crucial enzyme in BER and SSB repair (SSBR). We showed previously that inhibition of BER/SSBR by expressing a dominant negative DNA polymerase beta (polbetaDN) resulted in radiosensitization. We hypothesized increased kill to result from DSBs arising from unrepaired SSBs and BER intermediates. We find here higher numbers of IR-induced chromosome aberrations in polbetaDN expressing cells, confirming increased DSB formation. These aberrations did not result from changes in DSB induction or repair of the majority of lesions. SSB conversion to DSBs has been shown to occur during replication. We observed an increased induction of chromatid aberrations in polbetaDN expressing cells after IR, suggesting such a replication-dependence of secondary DSB formation. We also observed a pronounced increase of chromosomal deletions, the most likely cause of the increased kill. After H(2)O(2) treatment, polbetaDN expression only resulted in increased chromatid (not chromosome) aberrations. Together with the lack of sensitization to H(2)O(2), these data further suggest that the additional secondarily induced lethal DSBs resulted from repair attempts at complex clustered damage sites, unique to IR. Surprisingly, the polbetaDN induced increase in residual gammaH2AX foci number was unexpectedly low compared with the radiosensitization or induction of aberrations. Our data thus demonstrate the formation of secondary DSBs that are reflected by increased kill but not by residual gammaH2AX foci, indicating an escape from gammaH2AX-mediated DSB repair. In addition, we show that in the polbetaDN expressing cells secondary DSBs arise in a radiation-specific and partly replication-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19059500     DOI: 10.1016/j.dnarep.2008.11.008

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  8 in total

Review 1.  Targeting DNA polymerase ß for therapeutic intervention.

Authors:  Eva M Goellner; David Svilar; Karen H Almeida; Robert W Sobol
Journal:  Curr Mol Pharmacol       Date:  2012-01       Impact factor: 3.339

2.  DNA polymerase beta promoter mutations affect gene transcription, translation and the sensitivity of esophageal cancer cells to cisplatin treatment.

Authors:  Tao Wang; Wenqiao Zang; Yunyun Ma; Min Li; Xiaoyan Xuan; Na Wang; Rui Wu; Yuebai Li; Ziming Dong; Guoqiang Zhao
Journal:  Mol Biol Rep       Date:  2012-11-03       Impact factor: 2.316

3.  Cyclophilin B expression is associated with in vitro radioresistance and clinical outcome after radiotherapy.

Authors:  Paul D Williams; Charles R Owens; Jaroslaw Dziegielewski; Christopher A Moskaluk; Paul W Read; James M Larner; Michael D Story; William A Brock; Sally A Amundson; Jae K Lee; Dan Theodorescu
Journal:  Neoplasia       Date:  2011-12       Impact factor: 5.715

4.  Two novel determinants of etoposide resistance in small cell lung cancer.

Authors:  Malcolm H Lawson; Natalie M Cummings; Doris M Rassl; Roslin Russell; James D Brenton; Robert C Rintoul; Gillian Murphy
Journal:  Cancer Res       Date:  2011-06-03       Impact factor: 12.701

5.  Enhancement of silencing DNA polymerase β on the radiotherapeutic sensitivity of human esophageal carcinoma cell lines.

Authors:  Yuanyuan Wang; Xiaonan Chen; Xuanyu Hu; Ren Zhang; Yuwen Du; Wenqiao Zang; Ziming Dong; Guoqiang Zhao
Journal:  Tumour Biol       Date:  2014-10

Review 6.  Biological and therapeutic relevance of nonreplicative DNA polymerases to cancer.

Authors:  Jason L Parsons; Nils H Nicolay; Ricky A Sharma
Journal:  Antioxid Redox Signal       Date:  2012-09-05       Impact factor: 8.401

7.  Uncoupling DNA damage from chromatin damage to detoxify doxorubicin.

Authors:  Xiaohang Qiao; Sabina Y van der Zanden; Dennis P A Wander; Daniel M Borràs; Ji-Ying Song; Xiaoyang Li; Suzanne van Duikeren; Noortje van Gils; Arjo Rutten; Tessa van Herwaarden; Olaf van Tellingen; Elisa Giacomelli; Milena Bellin; Valeria Orlova; Leon G J Tertoolen; Sophie Gerhardt; Jimmy J Akkermans; Jeroen M Bakker; Charlotte L Zuur; Baoxu Pang; Anke M Smits; Christine L Mummery; Linda Smit; Ramon Arens; Junmin Li; Hermen S Overkleeft; Jacques Neefjes
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-17       Impact factor: 11.205

8.  Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin.

Authors:  Baoxu Pang; Xiaohang Qiao; Lennert Janssen; Arno Velds; Tom Groothuis; Ron Kerkhoven; Marja Nieuwland; Huib Ovaa; Sven Rottenberg; Olaf van Tellingen; Jeroen Janssen; Peter Huijgens; Wilbert Zwart; Jacques Neefjes
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.